Derek is responsible for identifying early stage targets, small molecules and monoclonal antibodies for our drug discovery group and the licensing of mature programmes to industry.
Derek Sheader
Latest news
-
The future of brain health: Early detection, equity and systematic change
-
Could a nasal insulin spray improve the lives of children and young people living with a rare condition?
-
Scientists test whether a finger prick blood test could be used to help diagnose Alzheimer’s disease before symptoms begin